Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease.

about

Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease.

Item

http://www.wikidata.org/entity/Q55050439

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Survival outcomes of patients ...... fractory or relapsing disease.

@en

Survival outcomes of patients ...... fractory or relapsing disease.

@nl

type

Item

label

Survival outcomes of patients ...... fractory or relapsing disease.

@en

Survival outcomes of patients ...... fractory or relapsing disease.

@nl

prefLabel

Survival outcomes of patients ...... fractory or relapsing disease.

@en

Survival outcomes of patients ...... fractory or relapsing disease.

@nl

P1476

Survival outcomes of patients ...... fractory or relapsing disease.

@en

P2093

Benjamin Krieger

http://www.w3.org/2001/XMLSchema#string

Carsten Grüllich

http://www.w3.org/2001/XMLSchema#string

Dirk Jäger

http://www.w3.org/2001/XMLSchema#string

Florian A Distler

http://www.w3.org/2001/XMLSchema#string

Georg Martin Haag

http://www.w3.org/2001/XMLSchema#string

Kerstin Schäfer-Eckart

http://www.w3.org/2001/XMLSchema#string

Maximilian Jenzer

http://www.w3.org/2001/XMLSchema#string

Patrick Wuchter

http://www.w3.org/2001/XMLSchema#string

Peter Dreger

http://www.w3.org/2001/XMLSchema#string

Stefanie Zschäbitz

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study Group.

Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.

Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know?

Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.

Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.

Platinum-refractory germ cell tumors: an update on current treatment options and developments.

Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.

High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.

Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' view.

Multidisciplinary Clinic Approach Improves Overall Survival Outcomes of Patients with Metastatic Germ Cell Tumors.

P304

22537-22545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25162

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Markus Hohenfellner

Sascha Pahernik

P577

2018-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29854297

http://www.w3.org/2001/XMLSchema#string

P932

5976483

http://www.w3.org/2001/XMLSchema#string